23ND 01
Alternative Names: 23ND-01; IN-A018Latest Information Update: 10 Apr 2024
At a glance
- Originator HK inno.N
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 31 Jul 2023 Early research in Cancer in South Korea (unspecified route) prior to July 2023 (HK inno.N pipeline, March 2024)